Jefferson Health in Philadelphia and National Jewish Health, (Denver) will create the Jane and Leonard Korman Respiratory Institute in Philadelphia. The Institute is enabled by the continuing support of the Jane and Leonard Korman Family Foundation.
The collaboration leverages the strengths of each organization and will define best practices for treatment and research of pulmonary and related diseases including COPD, asthma, interstitial lung disease, sarcoidosis and infectious respiratory diseases.
The Respiratory Institute is expected to open this summer, with additional locations anticipated across Jefferson Health’s regional campuses.
“This is a model for how organizations can work together to deliver more value to our patients by providing the right care in the communities we serve,” said Stephen K. Klasko, MD, MBA, President and CEO of Thomas Jefferson University and Jefferson Health. “Our partnership will transform the way pulmonary care is delivered, and we are looking forward to being part of a growing collaborative dedicated to the treatment and research of pulmonary and related diseases.”
The Respiratory Institute will provide a unique and deep patient care experience tailored for Jefferson Health. The Respiratory Institute also will focus on a research network, bringing together investigators to advance care for complex respiratory diseases.
In addition, the Jane and Leonard Korman Respiratory Institute will be integrated with the Respiratory Institute that National Jewish Health and Mount Sinai in New York established in 2014. Together, these three entities will collaborate on research, clinical trials and other programs that will serve patients throughout the Northeast in an unparalleled respiratory network.
